Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome

Nature Microbiology

Volumn 1, Issue 10, 2016, Pages

  Dickson, Robert P ^a   Singer, Benjamin H ^a   Newstead, Michael W ^a   Falkowski, Nicole R ^a   Erb Downward, John R ^a   Standiford, Theodore J ^a   Huffnagle, Gary B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; BACTERIUM; BACTEROIDES; BRONCHOALVEOLAR LAVAGE FLUID; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GASTROINTESTINAL TRACT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HIGH THROUGHPUT SEQUENCING; HUMAN; IMMUNOLOGY; INFLAMMATION; ISOLATION AND PURIFICATION; LUNG; MALE; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; MOUSE; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SEPSIS;

ADULT; ANIMALS; BACTERIA; BACTEROIDES; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL TRACT; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFLAMMATION; LUNG; MALE; MICE; MICROBIOTA; MIDDLE AGED; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84988919563     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/nmicrobiol.2016.113     Document Type: Article

References (65)

1. Angus, D. C. et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303-1310 (2001).
2. Rubenfeld, G. D. et al. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353, 1685-1693 (2005).
3. Hudson, L. D., Milberg, J. A., Anardi, D., Maunder, R. J. Clinical risks for development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151, 293-301 (1995).
4. Sheu, C. C. et al. Clinical characteristics and outcomes of sepsis-related vs nonsepsis-related ARDS. Chest 138, 559-567 (2010).
5. Dickson, R. P. The microbiome and critical illness. Lancet Respir. Med. 4, 59-72 (2016).
6. Fine, J., Frank, H., Schweinburg, F., Jacob, S., Gordon, T. The bacterial factor in traumatic shock. Ann. NY Acad. Sci. 55, 429-445 (1952).
7. Cuevas, P., De la Maza, L. M., Gilbert, J., Fine, J. The lung lesion in four different types of shock in rabbits. Arch. Surg. 104, 319-322 (1972).
8. Souza, D. G. et al. The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J. Immunol. 173, 4137-4146 (2004).
9. Silvestri, L., de la Cal, M. A., van Saene, H. K. Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth. Intens. Care Med. 38, 1738-1750 (2012).
10. Alverdy, J. C., Laughlin, R. S., Wu, L. Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined. Crit. Care Med. 31, 598-607 (2003).
11. Deitch, E. A. Gut-origin sepsis: evolution of a concept. Surgeon 10, 350-356 (2012).
12. Moore, F. A. et al. Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J. Trauma 31, 629-636; 636-628 (1991).
13. Walley, K. R., Lukacs, N. W., Standiford, T. J., Strieter, R. M., Kunkel, S. L. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 64, 4733-4738 (1996).
14. Oksanen, J. F. et al. Vegan: Community Ecology Package. R package version 2.0-4 (2012); http://CRAN.R-project.org/package=vegan
15. Wang, Y., Naumann, U., Wright, S. T., Warton, D. I. mvabund-an R package for model-based analysis of multivariate abundance data. Methods Ecol. Evol. 3, 471-474 (2012).
16. Evans, C. C. et al. Exercise prevents weight gain and alters the gut microbiota in a mouse model of high fat diet-induced obesity. PLoS ONE 9, e92193 (2014).
17. Devkota, S. et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10/mice. Nature 487, 104-108 (2012).
18. Musch, M. W., Wang, Y., Claud, E. C., Chang, E. B. Lubiprostone decreases mouse colonic inner mucus layer thickness and alters intestinal microbiota. Dig. Dis. Sci. 58, 668-677 (2013).
19. Poroyko, V. et al. Alterations of lung microbiota in a mouse model of LPSinduced lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 309, L76-L83 (2015).
20. Xu, J. et al. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 299, 2074-2076 (2003).
21. Kasai, C. et al. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol. 15, 100 (2015).
22. Eckburg, P. B. et al. Diversity of the human intestinal microbial flora. Science 308, 1635-1638 (2005).
23. Dickson, R. P. et al. Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations. PLoS ONE 9, e97214 (2014).
24. Osuchowski, M. F.,Welch, K., Siddiqui, J., Remick, D. G. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 177, 1967-1974 (2006).
25. Damas, P. et al. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit. Care Med. 17, 975-978 (1989).
26. Suter, P. M. et al. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am. Rev. Respir. Dis. 145, 1016-1022 (1992).
27. Meduri, G. U. et al. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 108, 1303-1314 (1995).
28. Hilty, M. et al. Disordered microbial communities in asthmatic airways. PLoS ONE 5, e8578 (2010).
29. Huang, Y. J. et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J. Allergy Clin. Immunol. 127, 372-381 (2011).
30. Sze, M. A. et al. Host response to the lung microbiome in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 192, 438-445 (2015).
31. Zhang, D. et al. Neutrophil ageing is regulated by the microbiome. Nature 525, 528-532 (2015).
32. Rush, B. F. Jr et al. Does the bacteremia observed in hemorrhagic shock have clinical significance A study in germ-free animals. Ann. Surg. 210, 342-345; 346-347 (1989).
33. Doig, C. J. et al. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am. J. Respir. Crit. Care Med. 158, 444-451 (1998).
34. Baker, J. W., Deitch, E. A., Li, M., Berg, R. D., Specian, R. D. Hemorrhagic shock induces bacterial translocation from the gut. J. Trauma 28, 896-906 (1988).
35. O'Boyle, C. J. et al. Microbiology of bacterial translocation in humans. Gut 42, 29-35 (1998).
36. Harris, B. et al. Gut microbiota predict pulmonary infiltrates after allogeneic hematopoietic cell transplantation. Am. J. Respir. Crit. Care Med. http://dx.doi.org/10.1164/rccm.201507-1491OC (2016).
37. Lemaire, L. C. et al. Thoracic duct in patients with multiple organ failure: no major route of bacterial translocation. Ann. Surg. 229, 128-136 (1999).
38. Suau, A. et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol. 65, 4799-4807 (1999).
39. Guo, S., Al-Sadi, R., Said, H. M., Ma, T. Y. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am. J. Pathol. 182, 375-387 (2013).
40. Adams, C. A. Jr, Xu, D. Z., Lu, Q., Deitch, E. A. Factors larger than 100 kD in post-hemorrhagic shock mesenteric lymph are toxic for endothelial cells. Surgery 129, 351-363 (2001).
41. Chastre, J. et al. Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 157, 1165-1172 (1998).
42. Kelly, B. J. et al. Composition and dynamics of the respiratory tract microbiome in intubated patients. Microbiome 4, 7 (2016).
43. Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174-180 (2011).
44. Morris, A. et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am. J. Respir. Crit. Care Med. 187, 1067-1075 (2013).
45. Segal, L. N. et al. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nature Microbiol. 1, 16031 (2016).
46. Santoro, A. E., Boehm, A. B. Frequent occurrence of the human-specific Bacteroides fecal marker at an open coast marine beach: relationship to waves, tides and traditional indicators. Environ. Microbiol. 9, 2038-2049 (2007).
47. Calfee, C. S. et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir. Med. 2, 611-620 (2014).
48. Zaborin, A. et al. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness. mBio 5, e01361-e01314 (2014).
49. Dickson, R. P., Martinez, F. J., Huffnagle, G. B. The role of the microbiome in exacerbations of chronic lung diseases. Lancet 384, 691-702 (2014).
50. Dickson, R. P., Erb-Downward, J. R., Huffnagle, G. B. Homeostasis and its disruption in the lung microbiome. Am. J. Physiol. Lung Cell Mol. Physiol. 309, L1047-L1055 (2015).
51. Steinhauser, M. L. et al. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J. Immunol. 162, 392-399 (1999).
52. Paine, R. 3rd et al. A randomized trial of recombinant human granulocytemacrophage colony stimulating factor for patients with acute lung injury. Crit. Care Med. 40, 90-97 (2012).
53. Bernard, G. R. et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149, 818-824 (1994).
54. Dickson, R. P. et al. Cell-associated bacteria in the human lung microbiome. Microbiome 2, 28 (2014).
55. Mason, K. L. et al. Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy. Infect. Immun. 80, 3371-3380 (2012).
56. Caporaso, J. G. et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl Acad. Sci. USA 108(Suppl 1), 4516-4522 (2011).
57. Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K., Schloss, P. D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl. Environ. Microbiol. 79, 5112-5120 (2013).
58. Schloss, P. D. 454 SOP-mothur (2015); http://www.mothur.org/wiki/454-SOP
59. Jumpstart Consortium Human Microbiome Project Data Generation Working Group Human Microbiome Consortium 16S 454 Sequencing Protocol (2010); http://hmpdacc.org/doc/16S-Sequencing-SOP-4.2.2.pdf
60. Daigle, D., Simen, B. B., Pochart, P. High-throughput sequencing of PCR products tagged with universal primers using 454 life sciences systems. Curr. Protoc. Mol. Biol. Chapter 7, Unit 7.5 (2011).
61. Schloss, P. D. MiSeq SOP-mothur (2015); http://www.mothur.org/wiki/MiSeq-SOP
62. Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75, 7537-7541 (2009).
63. R Core Team R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2013); http://www.R-project.org/
64. Legendre, P., Gallagher, E. D. Ecologically meaningful transformations for ordination of species data. Oecologia 129, 271-280.
65. Salter, S. J. et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 12, 87 (2014).